Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Moonwalk Biosciences has raised $70.0M in total funding. The most recent round was Series B. The last funding was announced in September 2026.
Moonwalk Biosciences's investors include Khosla Ventures, Gaorong Capital, Eli Lilly, ARCH Venture Partners, Alpha Wave Global.
Moonwalk Biosciences is headquartered in San Francisco, United States.
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Moonwalk Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moonwalk Biosciences — Funding & Investors." VCBacked, September 8, 2026, https://www.vcbacked.co/company/moonwalk-biosciences. Accessed October 17, 2026.
VCBacked. (2026). Moonwalk Biosciences — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/moonwalk-biosciences
{{cite web |title=Moonwalk Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/moonwalk-biosciences |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated